<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00098150</url>
  </required_header>
  <id_info>
    <org_study_id>Ext 1 to ASM981C202</org_study_id>
    <nct_id>NCT00098150</nct_id>
  </id_info>
  <brief_title>Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis</brief_title>
  <official_title>A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      This extension study is being conducted to collect post-treatment safety information on
      patients who previously participated in the core clinical trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <study_type>Observational</study_type>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Retrospective</time_perspective>
  </study_design_info>
  <enrollment>66</enrollment>
  <condition>Atopic Dermatitis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consenting patients who participated in the core clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2004</study_first_submitted>
  <study_first_submitted_qc>December 3, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2004</study_first_posted>
  <last_update_submitted>August 29, 2006</last_update_submitted>
  <last_update_submitted_qc>August 29, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2006</last_update_posted>
  <keyword>Safety, atopic dermatitis, adverse event, SAE, extension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pimecrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

